SLC1A2 and amyotrophic lateral sclerosis: MC1568 can also regulate the EAAT2 transcription, improve the EAAT2 expression and the post-translational modification, and has been proven to have the therapeutic effects in the subclinical models of ALS (Lapucci et al., 2017).